Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05RKV
|
|||
| Former ID |
DIB012716
|
|||
| Drug Name |
Sch-036
|
|||
| Synonyms |
Cannabinoid CB2 inverse agonists (immune disorders); Cannabinoid CB2 inverse agonists (immune disorders), Schering-Plough
Click to Show/Hide
|
|||
| Indication | Immune System disease [ICD-11: 4A01-4B41; ICD-10: D80-D89] | Investigative | [1] | |
| Company |
Schering-Plough Research Institute
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Agonist | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 57). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.